Form 13-F position report

BELLEROPHON THERAPEUTICS IN

Reported by GSA CAPITAL PARTNERS LLP

BLPH CUSIP 078771300 Manager CIK 0001362033

Reported 0 shares, down 63,566 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 4 Through Q2 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for BELLEROPHON THERAPEUTICS IN held by GSA CAPITAL PARTNERS LLP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

43 managers reported BELLEROPHON THERAPEUTICS IN for Q2 2021.

Managers reporting BELLEROPHON THERAPEUTICS IN in Q2 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 336,966 -22,193 < 0.01% $1,632,000 6 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 257,072 +23,273 < 0.01% $1,244,000 6 qtrs
WELLS FARGO & COMPANY MN Reduced 250,102 -1,314 < 0.01% $1,210,000 6 qtrs
BlackRock Inc Reduced 116,482 -205,300 < 0.01% $564,000 5 qtrs
Telemetry Investments L L C Added 90,920 +29,878 0.61% $440,000 6 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 58,380 -5,068 < 0.01% $282,000 6 qtrs
NORTHERN TRUST CORPORATION Reduced 36,555 -39,024 < 0.01% $177,000 5 qtrs
ACT CAPITAL MANAGEMENT LLC New 25,000 +25,000 0.06% $121,000 1 qtr
STATE STREET CORPORATION Reduced 21,027 -35,969 < 0.01% $102,000 5 qtrs
FIRST TRUST ADVISORS LP Reduced 20,515 -723 < 0.01% $99,000 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2021
Filed
August 05, 2021
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.